Novartis CEO Dr. Daniel Vasella made the commitment in Boston after hearing a plea from Life Raft Executive Director Norman Scherzer. The $2 million grant is the largest single donation for GIST cancer research in history. Scherzer made his pitch over breakfast with Vasella and David Epstein, president of Novartis Oncology. Scherzer noted that despite […]
The Latest News from the Life Raft Group
February 2008 clinical trial update
By Jim Hughes LRG Science Coordinator International AZD2171 Phase II: The AZD2171 Phase II Trial in the UK is now listed as “Not recruiting”. Dasatinib Phase II: This new trial for GIST is now open at Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, CH-1011. Dasatinib (BMS- 354825) is approved for leukemia (CML). Dasatinib is a […]